학술논문

Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
Document Type
Article
Source
In: JAMA Oncology. (JAMA Oncology, 21 December 2023, 9(12):1688-1695)
Subject
Language
English
ISSN
23742445
23742437